SIOC English
有机化学
高级检索

有机化学 >

2013 , Vol. 33 >Issue 03: 607 - 610

DOI: https://doi.org/10.6023/cjoc201210032

研究论文

1-(2,4-二氯苯基)-4-甲基-5-(4-氯苯基)吡唑-3-羧酸的新合成方法

  • 杨照 ,
  • 王志祥 ,
  • 方正 ,
  • 郭凯
展开
  • a 中国药科大学药学院 南京 210009;
    b 南京工业大学药学院 南京 210009

收稿日期: 2012-10-17

  修回日期: 2012-11-23

  网络出版日期: 2012-11-26

基金资助

国家重点基础研究发展计划(973计划, Nos. 2012CB725204, 2012CB721104)资助项目.

收起

A Novel Synthetic Method for 1-(2,4-Dichlorophenyl)-4-methyl- 5-(4-chlorophenyl)-1H-pyrazole-3-carboxylic Acid

  • Yang Zhao ,
  • Wang Zhixiang ,
  • Fang Zheng ,
  • Guo Kai
Expand
  • a College of Pharmacy, China Pharmaceutical of University, Nanjing 210009;
    b School of Pharmaceutical Science, Nanjing University of Technology, Nanjing 210009

Received date: 2012-10-17

  Revised date: 2012-11-23

  Online published: 2012-11-26

Supported by

Project supported by the National Key Basic Research Program of China (973 Program) (Nos. 2012CB725204, 2012CB721104).

Fold

摘要

研究了合成1-(2,4-二氯苯基)-4-甲基-5-(4-氯苯基)吡唑-3-羧酸的新方法. 以价廉、易得的对氯苯甲醛为原料, 经羟醛缩合、环合及氧化得目标化合物, 合成总收率为50.6%. 中间体及最终产物结构由1H NMR, MS确证. 该方法步骤较少、操作简便、收率良好, 是一条适合中试放大的新合成工艺路线.

本文引用格式

杨照 , 王志祥 , 方正 , 郭凯 . 1-(2,4-二氯苯基)-4-甲基-5-(4-氯苯基)吡唑-3-羧酸的新合成方法[J]. 有机化学, 2013 , 33(03) : 607 -610 . DOI: 10.6023/cjoc201210032

Abstract

A novel method for the synthesis of 1-(2,4-dichlorophenyl)-4-methyl-5-(4-chlorophenyl)-1H-pyrazole-3-carbox- ylic acid was reported. The target compound was prepared starting from 4-chlorobenzaldehyde, which is inexpensive and easily available starting material, via adol condensation, cyclization and oxidation with the total yield of 50.6%. The structures of intermediates and final product were determined by 1H NMR and MS. The novel method with the advantages of shorten process, easily conducted procedure and relatively high yield is suitable for scale-up production.

Key words： 1,5-diarylpyrazole; phenyl hydrazone; cyclization; oxidation; synthesis

参考文献

[1] (a) Munro, S.; Thomas, K. L.; Abu-Shaar, M. Nature 1993, 365, 61.
(b) Kyrou, I.; Valsamakis, G.; Tsigos, C. Ann. N. Y. Acad. Sci. 2006, 1083, 270.

[2] Akbas, F.; Gasteyger, C.; Sjödin, A.; Astrup, A.; Larsen, T. M. Obes. Rev. 2009, 10, 58.

[3] VanGaal, L. F.; Rissanen, A. M.; Scheen, A. J.; Ziegler, O.; Rossner, S. Lancet 2005, 365, 1387.

[4] (a) Vazquez, N.; Gomez-Vallejo, V.; Llop, J. Tetrahedron. Lett. 2012, 53, 4743.
(b) Tu, G. G.; Xiong, F.; Huang, H. M.; Kuang B. H.; Li, S. H. J. Enzyme Inhib. Med. Chem. 2011, 26, 222.
(c) Sasmal, P. K.; Reddy, D. S.; Talwar, R.; Venkatesham, B.; Balasubrahmanyam, D.; Kannan, M.; Srinivas, P.; Kumar, K. S.; Devi, B. N.; Jadhav, V. P.; Khan, S. K.; Mohan, P.; Chaudhury, H.; Bhuniya, D.; Iqbal, J.; Chakrabarti, R. Bioorg. Med. Chem. Lett. 2011, 21, 562.
(d) Wu, C.; Hung, M.; Song, J.; Yeh, T.; Chou, M.; Chu, C.; Jan, J.; Hsieh, M.; Tseng, S.; Chang, C.; Hsieh, W.; Lin, Y.; Yeh, Y.; Chung, W.; Kuo, C.; Lin, C.; Shy, H.; Chao, Y.; Shia, K. J. Med. Chem. 2009, 52, 4496.

[5] (a) Dutta, A. K.; Sard, H.; Ryan, W.; Razdan, R. K.; Compton, D. R.; Martin, B. R. Med. Chem. Res. 1995, 5, 54.
(b) Barth, F.; Casellas, P.; Congy, C.; Martinez, S.; Rinaldi, M.; Ann-Archard, G. EP 656354, 1994 [Chem. Abstr. 1994, 123, 286006].
(c) Tang, L.-H.; Tao, L.; Chen, H.-B.; Zhong, B.-H. Chin. J. Pharm. 2007, 38, 252 (in Chinese).
(汤立合, 陶林, 陈合兵, 仲伯华, 中国医药工业杂志, 2007, 38, 252.)
(d) Kotagiri, V. K.; Suthrapu, S.; Reddy, J. M.; Rao, C. P.; Bollugoddu, V.; Bhattacharya, A.; Bandichhor, R. Org. Process Res. Dev. 2007, 11, 910.
(e) Nerdinger, S. WO 2008101860, 2008 [Chem. Abstr. 2008, 149, 307838].
(f) Jin, W.-H.; Zhang, P.-Z.; Ji, Y.-F. Chin. J. Synth. Chem. 2010, 18, 397 (in Chinese).
(金文虎, 张鹏志, 冀亚飞, 合成化学, 2010, 18, 397. )

[6] Donohue, S. R.; Halldin, C.; Pike, V. W. Tetrahedron Lett. 2008, 49, 2789.

[7] Gomez, G. M.; Conde Jimenez, J. L.; Podio Lora, V. An. Quim.; Ser. C 1986, 82, 204.

[8] Stroh, H. H.; Lamprecht, H. Chem. Ber. 1963, 96, 651.

[9] Foye, W. O. J. Pharm. Sci. 1979, 68, 591.
Options
文章导航

/

〈 〉